Skip to main content

Advertisement

SpringerLink
Log in

Age-related Disparity: Breast Cancer in the Elderly

  • Geriatric Oncology (AR MacKenzie, Section Editor)
  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Aging poses an unique opportunity to study cancer biology and treatment in older adults. Breast cancer is often studied in young women; however, much investigation remains to be done on breast cancer in our expanding elderly population. Diagnostic and management strategies applicable to younger patients cannot be empirically used to manage older breast cancer patients. Lack of evidence-based data continues to be the major impediment toward delivery of personalized cancer care to elderly breast cancer patients. This article reviews the relevant literature on management of curable breast cancer in the elderly, the role of geriatric assessment, complex treatment decision making within the context of patient’s expected life expectancy, comorbidities, physical function, socioeconomic status, barriers to health care delivery, goals of treatment, and therapy-related side effects. Continuing efforts for enrolling elderly breast cancer patients in contemporary clinical trials, and thus improving age-appropriate care, are emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Tesarova P. Breast cancer in the elderly—Should it be treated differently? Rep Pract Oncol Radiother. 2013;18(1):26–33.

    Article  Google Scholar 

  2. American Cancer Society. Breast Cancer Facts & Figures 2013–2014. Atlanta: American Cancer Society, Inc. Available at: http://www.cancer.org/.

  3. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int J Cancer. 2012;136:E359–86.

    Article  CAS  Google Scholar 

  4. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2012

  5. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229–39.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wildiers H, Van Calster B, van de Poll-Franse L, et al. Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol. 2009;27:2931–7.

    Article  PubMed  Google Scholar 

  7. Anderson W, Katki H, Rosenberg P. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst. 2011;103:1397–402.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Markopoulos C, Van-de-Water W. Older patients with breast cancer: Is there bias in the treatment they receive? Ther Adv Med Oncol. 2012;4(6):321–7.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Smith B, Jiang J, McLaughlin S, et al. Improvement in breast cancer outcomes over time: Are older women missing Out? J Clin Oncol. 2011;29:4647–53.

    Article  PubMed  Google Scholar 

  10. Bastiaannet E, Liefers G, de Craen A, et al. Breast cancer in elderly compared to younger patients in The Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat. 2010;124:801–7.

    Article  CAS  PubMed  Google Scholar 

  11. Rosso S, Gondos A, Zanetti R, et al. Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer. 2010;46:3351–57.

    Article  PubMed  Google Scholar 

  12. Schonberg M, Marcantonio E, Li D, et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28:2038–45.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bouchardy C, Rapiti E, Fioretta G, et al. Under treatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003;21:3580–7.

    Article  PubMed  Google Scholar 

  14. Yancik R, Wesley MN, Ries LA, et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885–92.

    Article  CAS  PubMed  Google Scholar 

  15. Allemani C, Storm H, Voogd A, et al. Variation in ‘standard care’ for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer. 2010;46:1528–36.

    Article  PubMed  Google Scholar 

  16. Lavelle K, Moran A, Howell A, et al. Older women with operable breast cancer are less likely to have surgery. Br J Surg. 2007;94:1209–15.

    Article  CAS  PubMed  Google Scholar 

  17. Morgan J, Richards P, Francis M, et al. Case mix analysis and variation in rates of non-surgical treatment of older women with operable breast cancer. Br J Surg. 2015;102(9):1056–63.

    Article  CAS  PubMed  Google Scholar 

  18. Kiderlen M, Ponti A, Mariano T, et al. Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European society of breast cancer specialists database analysis. Eur J Cancer. 2015;51:1221–30.

    Article  PubMed  Google Scholar 

  19. Hughes K, Schnaper L, Bellon J, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Danese M, O’Malley C, Lindquist K, et al. An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol. 2012;23(7):1756–65.

    Article  CAS  PubMed  Google Scholar 

  21. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.

    Article  CAS  PubMed  Google Scholar 

  22. Saux OL et al. Optimal management of breast cancer in the elderly patient: current perspectives. Clin Interv Aging. 2015;10:157–74. An excellent and comprehensive review of multiple issues in the management of breast cancer in older patients

  23. Pallis A, Fortpied C, Wedding U, et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 2010;46:1502–13.

    Article  CAS  PubMed  Google Scholar 

  24. Hurria A, Wildes T, Baumgartner J, et al. NCCN Guidelines Version 1.2016 Older Adult Oncology. Available at: http://www.nccn.org/professionals/physician_gls/pdf/senior.pdf. Comprehensive guidelines for the management of elderly cancer patients, including supportive care issues.

  25. Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol. 2015;26(2):288–300.

    Article  CAS  PubMed  Google Scholar 

  26. Overcash J, Beckstead J, Moody L, et al. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol. 2006;59:205–10.

    Article  PubMed  Google Scholar 

  27. Fried L, Tangen C, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:146–56.

    Article  Google Scholar 

  28. Bellera C, Rainfray M, Mathoulin-Pélissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23:2166–72.

    Article  CAS  PubMed  Google Scholar 

  29. Saliba D, Elliott M, Rubenstein LZ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49:1691–9.

    Article  CAS  PubMed  Google Scholar 

  30. Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28:2046–50.

    Article  PubMed  Google Scholar 

  31. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104:1998–2005.

    Article  PubMed  Google Scholar 

  32. Hurria A, Cirrincione C, Muss H, et al. Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401. J Clin Oncol. 2011;29:1290–6. Describes the use of a comprehensive geriatric assessment tool in clinical trials.

  33. Hurria A, Togawa K, Mohile S, et al. Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study. J Clin Oncol. 2011;29:3457–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lee J, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295(7):801–8.

    Article  CAS  PubMed  Google Scholar 

  35. Schonberg M, Davis R, McCarthy E, et al. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med. 2009;24(10):1115–22.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Cruz M, Covinsky K, Widera E, et al. Predicting 10-year mortality for older adults. JAMA. 2013;309(9):874–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Schonberg M, Davis R, McCarthy E, et al. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59(8):1444–51.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Hind D,Wyld L, Reed MW. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer. 2007;96(7):1025–9.

  39. Fentiman IS, Christiaens MR, Paridaens R, et al. Treatment of operable breast cancer in the elderly: a randomized clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer. 2003;39(3):309–16.

    Article  CAS  PubMed  Google Scholar 

  40. Bates T, Riley DL, Houghton J, et al. Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg. 1991;78:591–4.

    Article  CAS  PubMed  Google Scholar 

  41. Mustache G, Ceccherini R, Milani S, et al. Italian Cooperative Group GRETA Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol. 2003;14:414–20.

    Article  Google Scholar 

  42. Fentiman IS, van Zijl J, Karydas I, et al. Treatment of operable breast cancer in the elderly: a randomized clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. Eur J Cancer. 2003;39(3):300–8.

    Article  CAS  PubMed  Google Scholar 

  43. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75. Describes the results of important American College of Surgeons Oncology Group (ACOSOG) Z0011 study.

  44. Ramesh H, Boase T, Audisio R. Risk assessment for cancer surgery in elderly patients. Clin Interv Aging. 2006;1(3):221–7.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Smith IE, Dowsett M, Ebbs SR, et al. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol. 2005;23:5108–16.32.

    Article  CAS  PubMed  Google Scholar 

  46. Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol. 2001;12:1527–32.33.

    Article  CAS  PubMed  Google Scholar 

  47. Preece PE, Wood RA, Mackie CR, et al. Tamoxifen as initial sole treatment for localised breast cancer in elderly women: a pilot study. Br Med J. 1982;284:869–70.

    Article  CAS  Google Scholar 

  48. Masuda N, Sagara Y, Kinoshita T, et al. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomized phase 3 trial. Lancet Oncol. 2012;13:345–52.34.

    Article  CAS  PubMed  Google Scholar 

  49. Llombart-Cussac A, Guerrero A, Galan A, et al. Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR [+] operable breast cancer. Clin Transl Oncol. 2012;14:125–31.36.

    Article  CAS  PubMed  Google Scholar 

  50. Hille U, Soergel P, Länger F, et al. Aromatase inhibitors as solely treatment in postmenopausal breast cancer patients. Breast J. 2012;18:145–50.37.

    Article  CAS  PubMed  Google Scholar 

  51. Dixon JM, Renshaw L, MacAskill EJ, et al. Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast Cancer Res Treat. 2009;113:145–51.

    Article  CAS  PubMed  Google Scholar 

  52. Colleoni M, Montagna E. Neoadjuvant therapy for ER-positive breast cancers. Ann Oncol. 2012;23:243–48. Review of literature of pre-operative endocrine therapy in hormone receptor positive breast cancer.

  53. Cataliotti L, Buzdar AU, Noguchi S, et al. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative “Arimidex” Compared to Tamoxifen (PROACT) trial. Cancer. 2006;106:2095–103.31.

    Article  CAS  PubMed  Google Scholar 

  54. Ellis MJ, Suman VJ, Hoog J, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011;29:2342–9.35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Berruti A, Generali D, Kaufmann M, et al. International expert consensus on primary systemic therapy in management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer. J Natl Cancer Inst Monogr. 2011;43:147–51.

    Article  Google Scholar 

  56. Crivellari D, Sun Z, Coates AS, et al. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1–98 trial. J Clin Oncol. 2008;26:1972–9.

    Article  CAS  PubMed  Google Scholar 

  57. Muss HB, Tu D, Ingle JN, et al. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17. J Clin Oncol. 2008;26:1956–64.

    Article  CAS  PubMed  Google Scholar 

  58. Puts MT, Tu HA, Tourangeau A, et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Ann Oncol. 2014;25:564–77.

    Article  CAS  PubMed  Google Scholar 

  59. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Verbrugghe M, Verhaeghe S, Lauwaert K, et al. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev. 2013;39:610–21.

    Article  CAS  PubMed  Google Scholar 

  61. Muss HB et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009;360(20):2055–65. Seminal CALGB 49907 randomized controlled trial comparing Capecitabine alone to standard chemotherapy in elderly breast cancer patients.

  62. Jones S, Holmes FA, O’Shaughnessy J, et al. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow up of U.S. Oncology Research Trial 9735. J. Clin Oncol. 2009;27:1177–83.

    Article  CAS  Google Scholar 

  63. Vaz-Luis I, Keating N, Lin N, et al. Duration and Toxicity of Adjuvant Trastuzumab in Older Patients with Early-Stage Breast Cancer: A Population-Based Study. J Clin Oncol. 2014;32:927–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Tolaney SM, Barry WT, Dang CT, et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015;372:134–41. A phase II single arm study describing the use of a de-escalated trastuzumab based regimen in the elderly breast cancer patients.

  65. Barcenas CH et al. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. JCO 2014 Vol. 32 No. 19.

  66. Hughes K, Schnaper L, Berry D, et al. Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer. N Engl J Med. 2004;351:971–7.

    Article  CAS  PubMed  Google Scholar 

  67. Kunkler I, Williams L, Jack W, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomized controlled trial. Lancet Oncol. 2015;16:266–73.

    Article  PubMed  Google Scholar 

  68. Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN guidelines Version 1.2016 Breast Cancer. Available at: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

  69. Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardization of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008;371:1098–107.

    Article  CAS  PubMed  Google Scholar 

  70. Haviland JS, Agrawal R, Aird E, et al. The UK START (Standardization of Breast Radiotherapy) Trials: 10-year follow-up results. Cancer Res. 2012;72:S3.

    Article  Google Scholar 

  71. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143–50.

    Article  PubMed  Google Scholar 

  72. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.

    Article  CAS  PubMed  Google Scholar 

  73. Dragun AE et al. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys. 2013;85(3):e123–8.

    Article  PubMed  Google Scholar 

  74. Nightingale G, Hajjar E, Swartz K, et al. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33:1453–9.

    Article  PubMed  Google Scholar 

  75. American Geriatrics Society 2012 Beers Criteria- Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31.

    Article  Google Scholar 

  76. Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37:673–9.

    Article  PubMed  Google Scholar 

  77. Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.

    Article  Google Scholar 

  78. Extermann M, Boler I, Reich R, et al. Predicting the Risk of Chemotherapy Toxicity in Older Patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score. Cancer. 2012;118:3377–86.

    Article  PubMed  Google Scholar 

  79. Hurria A, Mohile S, Gajra A, et al. Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. J Clin Oncol. 2016. doi:10.1200/JCO.2015.65.4327.

    Google Scholar 

  80. VanderWalde A, Hurria A. Aging and Osteoporosis in Breast and Prostate Cancer. CA Cancer J Clin. 2011;61:139–56.

    Article  PubMed  Google Scholar 

  81. Hillner B, Ingle J, Chlebowski R, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003;21(21):4042–57.

    Article  CAS  PubMed  Google Scholar 

  82. Gralow JR, Biermann J, Farooki A, et al. NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw. 2009;7 suppl 3:S1–S32. quiz S33-S35.

    PubMed  PubMed Central  Google Scholar 

  83. Reid DM, Doughty J, Eastell R, et al. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev. 2008;34 suppl 1:S3–S18.

    Article  CAS  PubMed  Google Scholar 

  84. Gosain R, Miller K. Symptoms and symptom management in long-term cancer survivors. Cancer J. 2013;19(5):405–9.

    Article  PubMed  Google Scholar 

  85. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care. 2007;5:273–80.

  86. Rao A, Cohen HJ. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr 2004:150–157.

  87. Naeim A, Aapro M, Subbarao R, et al. Supportive Care Considerations for Older Adults With Cancer. J Clin Oncol. 2014;20:2627–34.

    Article  Google Scholar 

  88. Gerber L, Stout N, Charles M, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cnacer. Support Care Cancer. 2011;19(10):1581–91.

    Article  PubMed  Google Scholar 

  89. Fu MR, Rosedale M. Breast Cancer Survivors’ Experiences of Lymphedema-Related Symptoms. J Pain Symptom Manag. 2009;38(6):849–59.

    Article  Google Scholar 

  90. Balci LF et al. Breast Cancer-Related Lymphedema in Elderly Patients. Geriatric Rehabil. 2012;28(4):243–53.

    Article  Google Scholar 

  91. Diell-Conwright CM, Orozco BZ. Exercise after breast cancer treatment: current perspectives. Breast Cancer: Targets Ther. 2015;7:353–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Medical Oncology, James Graham Brown Cancer Center, Louisville, KY, 40202, USA

    Rahul Gosain

  2. Department of Internal Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA

    YaoYao Pollock

  3. Division of Hematology and Medical Oncology, Multidisciplinary Breast Cancer Program, James Graham Brown Cancer Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA

    Dharamvir Jain

Authors
  1. Rahul Gosain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. YaoYao Pollock
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dharamvir Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dharamvir Jain.

Ethics declarations

Conflict of Interest

Rahul Gosain, YaoYao Pollock, and Dharamvir Jain declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Geriatric Oncology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gosain, R., Pollock, Y. & Jain, D. Age-related Disparity: Breast Cancer in the Elderly. Curr Oncol Rep 18, 69 (2016). https://doi.org/10.1007/s11912-016-0551-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11912-016-0551-8

Keywords

Search

Navigation